The global market for Platinum-based Anticancer APIs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
With the continuous deepening of research, platinum anti-cancer APIs such as cisplatin, carboplatin, nedaplatin, cycloplatin, oxaliplatin, and loplatin have been developed around the world. At present, platinum-based anticancer APIs have developed into the third generation. The mainstream platinum-based anticancer APIs are cisplatin, carboplatin and oxaliplatin.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer APIs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Platinum-based Anticancer APIs by region & country, by Type, and by Application.
The Platinum-based Anticancer APIs market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer APIs.
Market Segmentation
By Company
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
Segment by Type:
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Platinum-based Anticancer APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Platinum-based Anticancer APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Platinum-based Anticancer APIs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Platinum-based Anticancer APIs Product Introduction
1.2 Global Platinum-based Anticancer APIs Market Size Forecast
1.2.1 Global Platinum-based Anticancer APIs Sales Value (2019-2030)
1.2.2 Global Platinum-based Anticancer APIs Sales Volume (2019-2030)
1.2.3 Global Platinum-based Anticancer APIs Sales Price (2019-2030)
1.3 Platinum-based Anticancer APIs Market Trends & Drivers
1.3.1 Platinum-based Anticancer APIs Industry Trends
1.3.2 Platinum-based Anticancer APIs Market Drivers & Opportunity
1.3.3 Platinum-based Anticancer APIs Market Challenges
1.3.4 Platinum-based Anticancer APIs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Platinum-based Anticancer APIs Players Revenue Ranking (2023)
2.2 Global Platinum-based Anticancer APIs Revenue by Company (2019-2024)
2.3 Global Platinum-based Anticancer APIs Players Sales Volume Ranking (2023)
2.4 Global Platinum-based Anticancer APIs Sales Volume by Company Players (2019-2024)
2.5 Global Platinum-based Anticancer APIs Average Price by Company (2019-2024)
2.6 Key Manufacturers Platinum-based Anticancer APIs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Platinum-based Anticancer APIs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Platinum-based Anticancer APIs
2.9 Platinum-based Anticancer APIs Market Competitive Analysis
2.9.1 Platinum-based Anticancer APIs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Platinum-based Anticancer APIs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer APIs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cisplatin
3.1.2 Carboplatin
3.1.3 Oxaliplatin
3.1.4 Nedaplatin
3.1.5 Others
3.2 Global Platinum-based Anticancer APIs Sales Value by Type
3.2.1 Global Platinum-based Anticancer APIs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Platinum-based Anticancer APIs Sales Value, by Type (2019-2030)
3.2.3 Global Platinum-based Anticancer APIs Sales Value, by Type (%) (2019-2030)
3.3 Global Platinum-based Anticancer APIs Sales Volume by Type
3.3.1 Global Platinum-based Anticancer APIs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Platinum-based Anticancer APIs Sales Volume, by Type (2019-2030)
3.3.3 Global Platinum-based Anticancer APIs Sales Volume, by Type (%) (2019-2030)
3.4 Global Platinum-based Anticancer APIs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Testicular Cancer
4.1.2 Osteosarcoma
4.1.3 Breast Cancer
4.1.4 Esophageal Cancer
4.1.5 NSCLC
4.1.6 Other
4.2 Global Platinum-based Anticancer APIs Sales Value by Application
4.2.1 Global Platinum-based Anticancer APIs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Platinum-based Anticancer APIs Sales Value, by Application (2019-2030)
4.2.3 Global Platinum-based Anticancer APIs Sales Value, by Application (%) (2019-2030)
4.3 Global Platinum-based Anticancer APIs Sales Volume by Application
4.3.1 Global Platinum-based Anticancer APIs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Platinum-based Anticancer APIs Sales Volume, by Application (2019-2030)
4.3.3 Global Platinum-based Anticancer APIs Sales Volume, by Application (%) (2019-2030)
4.4 Global Platinum-based Anticancer APIs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Platinum-based Anticancer APIs Sales Value by Region
5.1.1 Global Platinum-based Anticancer APIs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Platinum-based Anticancer APIs Sales Value by Region (2019-2024)
5.1.3 Global Platinum-based Anticancer APIs Sales Value by Region (2025-2030)
5.1.4 Global Platinum-based Anticancer APIs Sales Value by Region (%), (2019-2030)
5.2 Global Platinum-based Anticancer APIs Sales Volume by Region
5.2.1 Global Platinum-based Anticancer APIs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Platinum-based Anticancer APIs Sales Volume by Region (2019-2024)
5.2.3 Global Platinum-based Anticancer APIs Sales Volume by Region (2025-2030)
5.2.4 Global Platinum-based Anticancer APIs Sales Volume by Region (%), (2019-2030)
5.3 Global Platinum-based Anticancer APIs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Platinum-based Anticancer APIs Sales Value, 2019-2030
5.4.2 North America Platinum-based Anticancer APIs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Platinum-based Anticancer APIs Sales Value, 2019-2030
5.5.2 Europe Platinum-based Anticancer APIs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Platinum-based Anticancer APIs Sales Value, 2019-2030
5.6.2 Asia Pacific Platinum-based Anticancer APIs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Platinum-based Anticancer APIs Sales Value, 2019-2030
5.7.2 South America Platinum-based Anticancer APIs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Platinum-based Anticancer APIs Sales Value, 2019-2030
5.8.2 Middle East & Africa Platinum-based Anticancer APIs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Platinum-based Anticancer APIs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Platinum-based Anticancer APIs Sales Value
6.2.1 Key Countries/Regions Platinum-based Anticancer APIs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Platinum-based Anticancer APIs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Platinum-based Anticancer APIs Sales Value, 2019-2030
6.3.2 United States Platinum-based Anticancer APIs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Platinum-based Anticancer APIs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Platinum-based Anticancer APIs Sales Value, 2019-2030
6.4.2 Europe Platinum-based Anticancer APIs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Platinum-based Anticancer APIs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Platinum-based Anticancer APIs Sales Value, 2019-2030
6.5.2 China Platinum-based Anticancer APIs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Platinum-based Anticancer APIs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Platinum-based Anticancer APIs Sales Value, 2019-2030
6.6.2 Japan Platinum-based Anticancer APIs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Platinum-based Anticancer APIs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Platinum-based Anticancer APIs Sales Value, 2019-2030
6.7.2 South Korea Platinum-based Anticancer APIs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Platinum-based Anticancer APIs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Platinum-based Anticancer APIs Sales Value, 2019-2030
6.8.2 Southeast Asia Platinum-based Anticancer APIs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Platinum-based Anticancer APIs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Platinum-based Anticancer APIs Sales Value, 2019-2030
6.9.2 India Platinum-based Anticancer APIs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Platinum-based Anticancer APIs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Jiangsu Hengrui Medicine
7.1.1 Jiangsu Hengrui Medicine Company Information
7.1.2 Jiangsu Hengrui Medicine Introduction and Business Overview
7.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Offerings
7.1.5 Jiangsu Hengrui Medicine Recent Development
7.2 Nanjing Pharmaceutical Factory
7.2.1 Nanjing Pharmaceutical Factory Company Information
7.2.2 Nanjing Pharmaceutical Factory Introduction and Business Overview
7.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Offerings
7.2.5 Nanjing Pharmaceutical Factory Recent Development
7.3 Qilu Pharmaceutical
7.3.1 Qilu Pharmaceutical Company Information
7.3.2 Qilu Pharmaceutical Introduction and Business Overview
7.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Qilu Pharmaceutical Platinum-based Anticancer APIs Product Offerings
7.3.5 Qilu Pharmaceutical Recent Development
7.4 Neptunus
7.4.1 Neptunus Company Information
7.4.2 Neptunus Introduction and Business Overview
7.4.3 Neptunus Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Neptunus Platinum-based Anticancer APIs Product Offerings
7.4.5 Neptunus Recent Development
7.5 Hisun
7.5.1 Hisun Company Information
7.5.2 Hisun Introduction and Business Overview
7.5.3 Hisun Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hisun Platinum-based Anticancer APIs Product Offerings
7.5.5 Hisun Recent Development
7.6 Jiangsu HaiCi biological pharmaceutical
7.6.1 Jiangsu HaiCi biological pharmaceutical Company Information
7.6.2 Jiangsu HaiCi biological pharmaceutical Introduction and Business Overview
7.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Offerings
7.6.5 Jiangsu HaiCi biological pharmaceutical Recent Development
7.7 Kunming Guiyan Pharmaceutical
7.7.1 Kunming Guiyan Pharmaceutical Company Information
7.7.2 Kunming Guiyan Pharmaceutical Introduction and Business Overview
7.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Offerings
7.7.5 Kunming Guiyan Pharmaceutical Recent Development
7.8 Lingnan Pharmacy
7.8.1 Lingnan Pharmacy Company Information
7.8.2 Lingnan Pharmacy Introduction and Business Overview
7.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Lingnan Pharmacy Platinum-based Anticancer APIs Product Offerings
7.8.5 Lingnan Pharmacy Recent Development
7.9 Jinzhou Jiutai Pharmaceutical
7.9.1 Jinzhou Jiutai Pharmaceutical Company Information
7.9.2 Jinzhou Jiutai Pharmaceutical Introduction and Business Overview
7.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Offerings
7.9.5 Jinzhou Jiutai Pharmaceutical Recent Development
7.10 Nanjing Hairun Pharmaceutical
7.10.1 Nanjing Hairun Pharmaceutical Company Information
7.10.2 Nanjing Hairun Pharmaceutical Introduction and Business Overview
7.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Offerings
7.10.5 Nanjing Hairun Pharmaceutical Recent Development
7.11 Simcere
7.11.1 Simcere Company Information
7.11.2 Simcere Introduction and Business Overview
7.11.3 Simcere Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Simcere Platinum-based Anticancer APIs Product Offerings
7.11.5 Simcere Recent Development
7.12 Teva
7.12.1 Teva Company Information
7.12.2 Teva Introduction and Business Overview
7.12.3 Teva Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Teva Platinum-based Anticancer APIs Product Offerings
7.12.5 Teva Recent Development
7.13 Cipla
7.13.1 Cipla Company Information
7.13.2 Cipla Introduction and Business Overview
7.13.3 Cipla Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Cipla Platinum-based Anticancer APIs Product Offerings
7.13.5 Cipla Recent Development
7.14 Heraeus
7.14.1 Heraeus Company Information
7.14.2 Heraeus Introduction and Business Overview
7.14.3 Heraeus Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Heraeus Platinum-based Anticancer APIs Product Offerings
7.14.5 Heraeus Recent Development
7.15 Hospira(Pfizer)
7.15.1 Hospira(Pfizer) Company Information
7.15.2 Hospira(Pfizer) Introduction and Business Overview
7.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Hospira(Pfizer) Platinum-based Anticancer APIs Product Offerings
7.15.5 Hospira(Pfizer) Recent Development
7.16 Taj Pharmaceuticals
7.16.1 Taj Pharmaceuticals Company Information
7.16.2 Taj Pharmaceuticals Introduction and Business Overview
7.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Taj Pharmaceuticals Platinum-based Anticancer APIs Product Offerings
7.16.5 Taj Pharmaceuticals Recent Development
7.17 Umicore Precious Metals Chemistry
7.17.1 Umicore Precious Metals Chemistry Company Information
7.17.2 Umicore Precious Metals Chemistry Introduction and Business Overview
7.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Offerings
7.17.5 Umicore Precious Metals Chemistry Recent Development
8 Industry Chain Analysis
8.1 Platinum-based Anticancer APIs Industrial Chain
8.2 Platinum-based Anticancer APIs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Platinum-based Anticancer APIs Sales Model
8.5.2 Sales Channel
8.5.3 Platinum-based Anticancer APIs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
听
听
*If Applicable.
